Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Total Debt / (EBITDA-CAPEX)

Rigel Pharmaceuticals Total Debt / (EBITDA-CAPEX) Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Total Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Rigel Pharmaceuticals Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $-1m a -26.12% increase of 0m year over year
  • Rigel Pharmaceuticals Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $-2m a 57.59% decrease of -1m year over year
  • Rigel Pharmaceuticals Annual Total Debt / (EBITDA-CAPEX) for 2019 was $-1m a 104.25% decrease of -1m from 2018
  • Rigel Pharmaceuticals Annual Total Debt / (EBITDA-CAPEX) for 2010 was $0m
Other Ratios Metrics:
  • Rigel Pharmaceuticals Total Debt / Capital for the quarter ending September 09, 2011 was $0m a -823.31% decrease of 0m year over year
  • Rigel Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a 91.46% increase of 1m year over year
  • Rigel Pharmaceuticals Total Debt / Equity for the quarter ending September 09, 2011 was $0m a -827.75% decrease of 0m year over year
View Chart On Koyfin

Quarterly RIGL Total Debt / (EBITDA-CAPEX) Data

06/2020$-1m
03/2020$0m
12/2019$-1m
09/2019$-1m
06/2019$0m
03/2019$0m
09/2011$0m
06/2011$0m
03/2011$0m
12/2010$0m

Annual RIGL Total Debt / (EBITDA-CAPEX) Data

2019$-1m
2010$0m